ArticleExperimental brain research2025
Darbepoetin alpha has neuroprotective effects in the hippocampus against long-term intermittent ethanol administration.
Article in Experimental brain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The consumption of ethanol has detrimental effects on several organs, including the brain. One of the most important targets of ethanol toxicity in the brain is the hippocampus. The aim of our study was to investigate the neuroprotective effects of darbepoetin alpha against neuronal damage caused by long-term intermittent ethanol exposure in the hippocampus. Forty male Wistar albino rats were divided into four groups: control (C), ethanol (E), darbepoetin alpha (DA), and ethanol + darbepoetin alpha (E + DA). In this study, oxidative stress and antioxidant markers, S100-β and neuron specific enolase (NSE) were investigated in both brain tissue and serum. Additionally, brain tissues were examined using histopathological methods. S100-β and NSE levels were significantly elevated in the E group compared to the C group in both the brain tissue and serum. Furthermore, catalase (CAT) and glutathione reductase (GR) levels, glutathione peroxidase (GPx) enzyme activities were significantly lower in both brain tissue and serum, while superoxide dismutase (SOD) enzyme activity in brain tissue was significantly reduced, and malondialdehyde (MDA) levels in brain tissue were markedly elevated in the E group. In the E + DA group, S100-β levels in both brain tissue and serum, NSE levels in serum, and MDA levels in brain tissue were significantly lower. Additionally, GPx activity in brain tissue and CAT levels in serum were significantly higher in the E + DA group compared to the E group. Histopathologically, the E group showed moderate neurodegeneration in the dentate gyrus, while the E + DA group exhibited mild neurodegeneration. In conclusion, DA reversed the degenerative effects of long-term intermittent ethanol exposure on the hippocampus by improving oxidative stress parameters and reducing neuronal injury.
Indexed as
Identifiers
40278889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.